Expanding Noninvasive Prenatal Testing (NIPT) to Average Risk: MaterniT® 21 PLUS Performance in the Average Risk vs. High Risk Population

February 22, 2017
Previous Flipbook
Spanish MaterniT 21 PLUS ESS patient brochure_Rep-1054-v1-0217
Spanish MaterniT 21 PLUS ESS patient brochure_Rep-1054-v1-0217

Next Flipbook
Optimized Detection of 22q11.2 Deletions Using Whole Genome Sequencing
Optimized Detection of 22q11.2 Deletions Using Whole Genome Sequencing